Healthcare -
Biotechnology - NASDAQ - US
$ 10.39
-1.14 %
$ 1.06 B
Market Cap
-1.91
P/E
NTLA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NTLA - Intellia Therapeutics, Inc.
130 M
LAST VALUE
-57.94%
2 YEAR CAGR
26.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR